Back
Meta Platforms Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Buy
78
META
Meta Platforms
Last Price:
567.47
Seasonality Move:
9.16%
Sell
47
RARE
Ultragenyx Pharmaceutical
Last Price:
54.79
Seasonality Move:
12.42%
Buy
78
Meta Platforms (META)
is a Buy
Is Meta Platforms a Buy, Sell or Hold?
- The current Meta Platforms [META] share price is $563.69. The Score for META is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
- META is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
47
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $54.69. The Score for RARE is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
META Stock Price Chart
What is Meta Platforms's stock price today?
-
The Meta Platforms share price today is $563.69
The current trend is moderately bearish and META is experiencing selling pressure, which indicates risk of future bearish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $54.69
The current trend is moderately bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
META Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 8.38 | Buy |
Relative Strength Index (14 RSI): | 46.54 | Sell |
Chaikin Money Flow: | -12001216 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (562.29 - 588.29) | Sell |
Bollinger Bands (100): | (486.05 - 558.57) | Buy |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 46.74 | Sell |
Chaikin Money Flow: | -417236 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (53.89 - 57.39) | Sell |
Bollinger Bands (100): | (42.72 - 56.34) | Buy |
META Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 580.09 | Sell |
20-day SMA: | 579.81 | Sell |
50-day SMA: | 548.66 | Buy |
200-day SMA: | 493.48 | Buy |
8-day EMA: | 577.19 | Sell |
20-day EMA: | 573.69 | Sell |
50-day EMA: | 552.47 | Buy |
200-day EMA: | 484 | Buy |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 55.79 | Sell |
20-day SMA: | 55.04 | Sell |
50-day SMA: | 55.76 | Sell |
200-day SMA: | 47.58 | Buy |
8-day EMA: | 55.24 | Sell |
20-day EMA: | 55.36 | Sell |
50-day EMA: | 54.2 | Buy |
200-day EMA: | 48.52 | Buy |
Meta Platforms Earnings Growth & META Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.94 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.01 per share, and an increase next year of $3.21 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.05 per share, and an increase next year of $1.10 per share.
Meta Platforms Technical Analysis
Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |